10-Q Filing

IMMIX BIOPHARMA, INC. CIK: 1873835 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0001493152-24-018458`
Period End Date	20240331
Filing Date	20240509
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 142 Income Statement 80 Cash Flow Statement 118 Stockholders Equity 46

Balance Sheet 142 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.32M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.32M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.51M	USD	Point-in-time
Tax receivable	`IncomeTaxReceivable`	$1.17M	USD	Point-in-time
Tax receivable	`IncomeTaxReceivable`	$1.17M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Tax receivable	`IncomeTaxReceivable`	$2.02M	USD	Point-in-time
Tax receivable	`IncomeTaxReceivable`	$2.02M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.11M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.11M	USD	Point-in-time
Common stock par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.57M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.57M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$32.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$32.92M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.79M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.79M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	19.99M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	19.99M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$20.42K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$20.42K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.47M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.47M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.40M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.40M	shares	Point-in-time
Deferred offering cost	`DeferredCosts`	$87.23K	USD	Point-in-time
Deferred offering cost	`DeferredCosts`	$87.23K	USD	Point-in-time
Deferred offering cost	`DeferredCosts`	-	USD	Point-in-time
Deferred offering cost	`DeferredCosts`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	19.92M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	19.92M	shares	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$1.05M	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$1.05M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	72,363.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$360.83K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$360.83K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$50.18K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$50.18K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$50.18K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$50.18K	USD	Point-in-time
Total assets	`Assets`	$34.35M	USD	Point-in-time
Total assets	`Assets`	$34.35M	USD	Point-in-time
Total assets	`Assets`	$19.93M	USD	Point-in-time
Total assets	`Assets`	$19.93M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.72M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.72M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$5.62M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$5.62M	USD	Point-in-time
Operating lease liability - current	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liability - current	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liability - current	`OperatingLeaseLiabilityCurrent`	$34.28K	USD	Point-in-time
Operating lease liability - current	`OperatingLeaseLiabilityCurrent`	$34.28K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.66M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.66M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.72M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.72M	USD	Point-in-time
Operating lease liability long term	`OperatingLeaseLiabilityNoncurrent`	$1.06M	USD	Point-in-time
Operating lease liability long term	`OperatingLeaseLiabilityNoncurrent`	$1.06M	USD	Point-in-time
Operating lease liability long term	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Operating lease liability long term	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$6.72M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.72M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.72M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.72M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 26,468,783 shares issued and 26,396,420 shares outstanding at March 31, 2024 and 19,994,719 shares issued and 19,922,356 shares outstanding at December 31, 2023	`CommonStockValue`	$2.65K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 26,468,783 shares issued and 26,396,420 shares outstanding at March 31, 2024 and 19,994,719 shares issued and 19,922,356 shares outstanding at December 31, 2023	`CommonStockValue`	$2.65K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 26,468,783 shares issued and 26,396,420 shares outstanding at March 31, 2024 and 19,994,719 shares issued and 19,922,356 shares outstanding at December 31, 2023	`CommonStockValue`	$2.00K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 26,468,783 shares issued and 26,396,420 shares outstanding at March 31, 2024 and 19,994,719 shares issued and 19,922,356 shares outstanding at December 31, 2023	`CommonStockValue`	$2.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.59M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.59M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$69.78M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$69.78M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$89.61K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$89.61K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$134.67K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$134.67K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-58.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-58.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-53.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-53.41M	USD	Point-in-time
Treasury stock at cost, 72,363 shares as of March 31, 2024 and December 31, 2023	`TreasuryStockValue`	$99.96K	USD	Point-in-time
Treasury stock at cost, 72,363 shares as of March 31, 2024 and December 31, 2023	`TreasuryStockValue`	$99.96K	USD	Point-in-time
Treasury stock at cost, 72,363 shares as of March 31, 2024 and December 31, 2023	`TreasuryStockValue`	$99.96K	USD	Point-in-time
Treasury stock at cost, 72,363 shares as of March 31, 2024 and December 31, 2023	`TreasuryStockValue`	$99.96K	USD	Point-in-time
Total Immix Biopharma, Inc. stockholders equity	`StockholdersEquity`	$27.92M	USD	Point-in-time
Total Immix Biopharma, Inc. stockholders equity	`StockholdersEquity`	$27.92M	USD	Point-in-time
Total Immix Biopharma, Inc. stockholders equity	`StockholdersEquity`	$16.41M	USD	Point-in-time
Total Immix Biopharma, Inc. stockholders equity	`StockholdersEquity`	$16.41M	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$-283.28K	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$-283.28K	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$-201.74K	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$-201.74K	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.16M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.16M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$34.35M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$34.35M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$19.93M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$19.93M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.20M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.20M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.34M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.32M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.32M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.52M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.52M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.59M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.59M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.52M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.52M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.59M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.59M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$267.91K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$267.91K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$27.89K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$27.89K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$27.89K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$27.89K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$267.91K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$267.91K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.49M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.49M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.32M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.32M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.17K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.17K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$8.84K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$8.84K	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-18.37K	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-18.37K	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-72.07K	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-72.07K	USD	1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders	`NetIncomeLoss`	$-5.26M	USD	1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders	`NetIncomeLoss`	$-5.26M	USD	1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders	`NetIncomeLoss`	$-2.48M	USD	1 Quarter
Net loss attributable to Immix Biopharma, Inc. common stockholders	`NetIncomeLoss`	$-2.48M	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.47K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.47K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-45.05K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-45.05K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-45.05K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-45.05K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-4.47K	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-4.47K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-2.48M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-2.48M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-5.30M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-5.30M	USD	1 Quarter
Less: comprehensive loss attributable to non-controlling interests	`OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: comprehensive loss attributable to non-controlling interests	`OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: comprehensive loss attributable to non-controlling interests	`OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: comprehensive loss attributable to non-controlling interests	`OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders	`ComprehensiveIncomeNetOfTax`	$-2.48M	USD	1 Quarter
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders	`ComprehensiveIncomeNetOfTax`	$-2.48M	USD	1 Quarter
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders	`ComprehensiveIncomeNetOfTax`	$-5.30M	USD	1 Quarter
Comprehensive loss attributable to Immix Biopharma, Inc. common stockholders	`ComprehensiveIncomeNetOfTax`	$-5.30M	USD	1 Quarter
Loss per common share - basic	`EarningsPerShareBasic`	$-0.22	USD	1 Quarter
Loss per common share - basic	`EarningsPerShareBasic`	$-0.22	USD	1 Quarter
Loss per common share - basic	`EarningsPerShareBasic`	$-0.18	USD	1 Quarter
Loss per common share - basic	`EarningsPerShareBasic`	$-0.18	USD	1 Quarter
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.22	USD	1 Quarter
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.22	USD	1 Quarter
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.18	USD	1 Quarter
Loss per common share - diluted	`EarningsPerShareDiluted`	$-0.18	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	13.90M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	13.90M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	23.44M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	23.44M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	23.44M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	23.44M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	13.90M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	13.90M	shares	1 Quarter

Cash Flow Statement 118 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-2.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$329.92K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$329.92K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$943.26K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$943.26K	USD	1 Quarter
Depreciation	`Depreciation`	$3.01K	USD	1 Quarter
Depreciation	`Depreciation`	$3.01K	USD	1 Quarter
Depreciation	`Depreciation`	$505.00	USD	1 Quarter
Depreciation	`Depreciation`	$505.00	USD	1 Quarter
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	-	USD	1 Quarter
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	-	USD	1 Quarter
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	$20.84K	USD	1 Quarter
Amortization of right of use asset	`FinanceLeaseRightOfUseAssetAmortization`	$20.84K	USD	1 Quarter
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$72.19K	USD	1 Quarter
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$72.19K	USD	1 Quarter
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$911.54K	USD	1 Quarter
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$911.54K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$43.01K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$43.01K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$476.99K	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$476.99K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherCurrentAssets`	$20.42K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherCurrentAssets`	$20.42K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherCurrentAssets`	-	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherCurrentAssets`	-	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$190.81K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$190.81K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.92M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.92M	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$21.31K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$21.31K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.09M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.09M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.83M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.83M	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$301.91K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$301.91K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-301.91K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-301.91K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Payments of deferred offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	1 Quarter
Payments of deferred offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	1 Quarter
Payments of deferred offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	$160.00K	USD	1 Quarter
Payments of deferred offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	$160.00K	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$103.92K	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$103.92K	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$15.95M	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$15.95M	USD	1 Quarter
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$13.57M	USD	Point-in-time
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$13.57M	USD	Point-in-time
Proceeds from exercise of stock options	`ProceedsFromIssuanceInitialPublicOffering`	$2.49K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromIssuanceInitialPublicOffering`	$2.49K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	1 Quarter
Funds received for subsidiary private offering	`ProceedsFromIssuanceOfPrivatePlacement`	$175.00K	USD	1 Quarter
Funds received for subsidiary private offering	`ProceedsFromIssuanceOfPrivatePlacement`	$175.00K	USD	1 Quarter
Funds received for subsidiary private offering	`ProceedsFromIssuanceOfPrivatePlacement`	-	USD	1 Quarter
Funds received for subsidiary private offering	`ProceedsFromIssuanceOfPrivatePlacement`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$118.92K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$118.92K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$15.95M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$15.95M	USD	1 Quarter
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-10.37K	USD	1 Quarter
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-10.37K	USD	1 Quarter
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-562.00	USD	1 Quarter
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-562.00	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.97M	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.97M	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.81M	USD	1 Quarter
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.81M	USD	1 Quarter
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$11.46M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$11.46M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.44M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.44M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.51M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.51M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.32M	USD	Point-in-time
Cash and cash equivalents beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.32M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$11.46M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$11.46M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.44M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.44M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.51M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.51M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.32M	USD	Point-in-time
Cash and cash equivalents end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$29.32M	USD	Point-in-time
Income taxes paid	`IncomeTaxesPaidNet`	$8.84K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$8.84K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$5.17K	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$5.17K	USD	1 Quarter
Establishment of right of use asset and liabilities	`RightOfUseAssetAndLiabilities`	-	USD	1 Quarter
Establishment of right of use asset and liabilities	`RightOfUseAssetAndLiabilities`	-	USD	1 Quarter
Establishment of right of use asset and liabilities	`RightOfUseAssetAndLiabilities`	$1.07M	USD	1 Quarter
Establishment of right of use asset and liabilities	`RightOfUseAssetAndLiabilities`	$1.07M	USD	1 Quarter
Purchase of property and equipment included in accounts payable and accrued expenses	`PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses`	$11.75K	USD	1 Quarter
Purchase of property and equipment included in accounts payable and accrued expenses	`PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses`	$11.75K	USD	1 Quarter
Purchase of property and equipment included in accounts payable and accrued expenses	`PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses`	-	USD	1 Quarter
Purchase of property and equipment included in accounts payable and accrued expenses	`PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpenses`	-	USD	1 Quarter
Deferred offering costs charged against proceeds from sale of common stock	`DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock`	$2.59K	USD	1 Quarter
Deferred offering costs charged against proceeds from sale of common stock	`DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock`	$2.59K	USD	1 Quarter
Deferred offering costs charged against proceeds from sale of common stock	`DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock`	$87.23K	USD	1 Quarter
Deferred offering costs charged against proceeds from sale of common stock	`DeferredOfferingCostsChargedAgainstProceedsFromSaleOfCommonStock`	$87.23K	USD	1 Quarter
Nexcella shares issued for funds previously received	`SharesIssuedForFundsPreviouslyReceived`	-	USD	1 Quarter
Nexcella shares issued for funds previously received	`SharesIssuedForFundsPreviouslyReceived`	-	USD	1 Quarter
Nexcella shares issued for funds previously received	`SharesIssuedForFundsPreviouslyReceived`	$475.00K	USD	1 Quarter
Nexcella shares issued for funds previously received	`SharesIssuedForFundsPreviouslyReceived`	$475.00K	USD	1 Quarter
Accrual of deferred offering costs	`AccrualOfDeferredOfferingCosts`	-	USD	1 Quarter
Accrual of deferred offering costs	`AccrualOfDeferredOfferingCosts`	-	USD	1 Quarter
Accrual of deferred offering costs	`AccrualOfDeferredOfferingCosts`	$11.00K	USD	1 Quarter
Accrual of deferred offering costs	`AccrualOfDeferredOfferingCosts`	$11.00K	USD	1 Quarter

Stockholders Equity 46 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.16M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.16M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Shares issued under ATM facility for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts`	$338.50K	USD	1 Quarter
Shares issued under ATM facility for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts`	$338.50K	USD	1 Quarter
Shares issued under ATM facility for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts`	$101.32K	USD	1 Quarter
Shares issued under ATM facility for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueUnderAtmFacilitiesForCashProceedsNetOfOfferingCosts`	$101.32K	USD	1 Quarter
Shares issued under public offering for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$15.52M	USD	1 Quarter
Shares issued under public offering for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$15.52M	USD	1 Quarter
Shares issued for exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.49K	USD	1 Quarter
Shares issued for exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.49K	USD	1 Quarter
Shares issued for exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1,251.00	shares	1 Quarter
Shares issued for exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	1,251.00	shares	1 Quarter
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$327.38K	USD	1 Quarter
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$327.38K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$615.89K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$615.89K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$329.92K	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$329.92K	USD	1 Quarter
Non-controlling interests in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	1 Quarter
Non-controlling interests in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	1 Quarter
Non-controlling interests in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	1 Quarter
Non-controlling interests in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.50M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.33M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-45.05K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-45.05K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-4.47K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-4.47K	USD	1 Quarter
Nexcella shares issued for cash proceeds	`StockIssuedDuringPeriodValueOther`	$650.00K	USD	1 Quarter
Nexcella shares issued for cash proceeds	`StockIssuedDuringPeriodValueOther`	$650.00K	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.74M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.16M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.16M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.20M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.63M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.